Jinling Pharmaceutical Company Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 708.53 million compared to CNY 693.02 million a year ago. Revenue was CNY 708.53 million compared to CNY 693.02 million a year ago.

Net income was CNY 43.59 million compared to CNY 39.24 million a year ago. Basic earnings per share from continuing operations was CNY 0.0865 compared to CNY 0.0769 a year ago. Diluted earnings per share from continuing operations was CNY 0.0865 compared to CNY 0.0769 a year ago.